| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 |
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-102,377 | 24,854 | 33,880 | -227,937 | 26,648 | 115,292 | 123,717 |
Adjustments to reconcile net loss to cash provided by operating activities: | ||||||
Depreciation and amortization | ||||||
162,557 | 123,922 | 107,824 | 132,886 | 146,318 | 170,088 | 140,417 |
Impairments | ||||||
74,373 | 3,858 | 5,700 | 14,495 | 20,788 | 3,851 | 11,941 |
Amortization of deferred financing costs | ||||||
2,512 | 3,347 | 4,714 | 4,584 | 702 | 0 | 0 |
(Income) loss from discontinued operations, net of tax | ||||||
6,486 | 24,462 | 39,736 | -56,171 | 4,723 | 67,183 | 66,149 |
Provision for doubtful accounts | ||||||
32 | 86 | 863 | 2,972 | 3,326 | 679 | 2,317 |
Gain on sale of property, plant and equipment | ||||||
3,187 | 629 | 2,517 | 2,986 | 1,805 | 1,752 | 3,398 |
Income (Loss) from Equity Method Investments | ||||||
- | - | - | 10,403 | 15,152 | 14,553 | 19,000 |
Gain on remeasurement of intercompany balances | ||||||
300 | -5,200 | 500 | 9,300 | -30,127 | -3,614 | -4,313 |
Loss on foreign currency derivatives | ||||||
-794 | 0 | 0 | -709 | 0 | 0 | - |
Loss on sale of businesses | ||||||
0 | -1,714 | -111 | 0 | 0 | -961 | 0 |
Stock-based compensation expense | ||||||
12,750 | 14,567 | 14,764 | 10,966 | 8,184 | 5,288 | 5,330 |
Deferred income tax expense (benefit) | ||||||
-10,007 | 1,537 | -3,193 | 71,090 | -25,838 | 11,338 | 20,052 |
Changes in assets and liabilities: | ||||||
Accounts receivable and notes | ||||||
-50,730 | -8,669 | 65,311 | -126,276 | -34,428 | 51,234 | 15,239 |
Inventory | ||||||
8,369 | 59,676 | -20,594 | -49,736 | -80,416 | 11,855 | 23,894 |
Costs and estimated earnings versus billings on uncompleted contracts | ||||||
0 | 0 | -40,949 | -24,637 | 24,328 | 21,376 | 32,518 |
Contract assets | ||||||
-28,352 | 34,571 | 0 | 0 | - | - | - |
Other current assets | ||||||
-20,312 | -5,045 | 1,541 | 7,074 | 162 | 3,888 | -23,264 |
Accounts payable and other liabilities | ||||||
-41,092 | 13,801 | 62,029 | 2,078 | -82,595 | 24,855 | 30,174 |
Deferred revenue | ||||||
0 | 0 | -13,711 | 24,414 | -2,428 | -9,913 | -14,322 |
Contract liabilities | ||||||
-8,263 | 62,934 | 0 | 0 | - | - | - |
Other | ||||||
-3,854 | -3,059 | 14,483 | 857 | 4,806 | 19,709 | 22,361 |
Net cash provided by continuing operations | ||||||
176,198 | 153,296 | 150,420 | 262,489 | 189,100 | 134,503 | 164,644 |
Net cash provided by (used in) discontinued operations | ||||||
2,528 | 4,004 | -1,794 | 1,016 | -57,404 | 16,462 | 5,866 |
Net cash provided by operating activities | ||||||
178,726 | 157,300 | 148,626 | 263,505 | 131,696 | 150,965 | 170,510 |
Cash flows from investing activities: | ||||||
Capital expenditures | ||||||
193,274 | 215,108 | 131,673 | 73,670 | 155,344 | 156,602 | 100,195 |
Proceeds from sale of property, plant and equipment | ||||||
19,662 | 2,530 | 8,866 | 2,814 | 6,609 | 12,219 | 21,264 |
Proceeds from Divestiture of Businesses | ||||||
0 | 5,000 | 894 | 0 | 0 | 1,516 | 0 |
Proceeds from Sale of Equity Method Investments | ||||||
- | - | - | 10,403 | 15,185 | 14,750 | 19,000 |
Proceeds received from settlement of note receivable | ||||||
- | - | - | - | 5,357 | 0 | 0 |
Settlement of foreign currency derivatives | ||||||
794 | 0 | 0 | 709 | 0 | 0 | - |
Decrease in restricted cash | ||||||
- | - | - | - | 0 | 221 | -14 |
Cash invested in non-consolidated affiliates | ||||||
- | - | - | - | 33 | 197 | 0 |
Net cash used in continuing operations | ||||||
-174,406 | -207,578 | -121,913 | -61,162 | -128,226 | -128,535 | -59,917 |
Cash Provided by (Used in) Investing Activities, Discontinued Operations | ||||||
0 | 17,009 | 19,575 | 36,079 | 46,112 | 64,958 | 74,830 |
Net cash used in investing activities | ||||||
-174,406 | -190,569 | -102,338 | -25,083 | -82,114 | -63,577 | 14,913 |
Cash flows from financing activities: | ||||||
Proceeds from borrowings of debt | ||||||
642,500 | 585,014 | 501,088 | 430,758 | 673,500 | 0 | 0 |
Repayments of debt | ||||||
603,951 | 550,497 | 476,503 | 610,261 | 143,500 | 0 | 0 |
Payment for Spin-off Transaction | ||||||
-420 | 18,744 | 44,720 | 49,176 | 532,578 | 0 | 0 |
Net distributions to parent | ||||||
- | - | - | - | 40,218 | 79,296 | 182,909 |
Payments for debt issuance costs | ||||||
0 | 4,801 | 7,911 | 779 | 13,345 | 0 | 0 |
Proceeds from stock options exercised | ||||||
0 | 548 | 684 | 786 | 0 | 0 | - |
Purchases of treasury stock (Note 10) | ||||||
45,007 | 4,623 | 4,792 | 2,091 | 54 | 0 | 0 |
Other | ||||||
- | - | - | - | - | 0 | - |
Net cash provided by financing activities | ||||||
-6,038 | 6,897 | -32,154 | -230,763 | -56,195 | -79,296 | -182,909 |
Effect of exchange rate changes on cash, cash equivalents and restricted cash | ||||||
-1,058 | -3,841 | -792 | -1,832 | -3,716 | -3,925 | -1,487 |
Net increase (decrease) in cash, cash equivalents and restricted cash | ||||||
-2,776 | -30,213 | 13,342 | 5,827 | -10,329 | 4,167 | 1,027 |
Supplemental disclosure of non-cash transactions: | ||||||
Income taxes paid, net | ||||||
30,436 | 11,601 | 47,403 | 57,580 | 64,683 | 63,349 | 73,271 |
Interest paid, net of capitalized amounts | ||||||
35,891 | 26,278 | 28,178 | 29,046 | 4,141 | 1,905 | 3,551 |
Supplemental disclosure of non-cash transactions: | ||||||
Net transfers of property, plant and equipment from parent prior to the Spin-off | ||||||
- | - | - | - | 7,627 | 17,472 | -12,578 |
Transfer of net deferred tax liabilities from parent at Spin-off | ||||||
- | - | - | - | 29,203 | 0 | 0 |
Accrued capital expenditures | ||||||
5,711 | 21,479 | 16,735 | 5,985 | 2,743 | 15,426 | 6,442 |
Non-cash proceeds from the sale of a plant | ||||||
- | - | - | 7,000 | 0 | 0 | - |
Non-cash proceeds from sale of business | ||||||
0 | 14,573 | 0 | 0 | - | - | - |